Data Supporting the Cardiovascular Safety of VIVUS’ Qsymia® Published in The Journal of Clinical Endocrinology & Metabolism

    NEXT STORY
    Medovex Corporation Closes Acquisition of Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC
    PREV STORY
    Recent Study Validates the Operational Effectiveness of Microbot Medical’s Self-Cleaning Shunt (SCS™)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cascadian Therapeutics Strengthens Management Team with Key Hires, Monique M. Greer and Marc C. Chamberlain, M.D.

    SEATTLE, Nov. 28, 2016 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Zomedica Provides Product Development Update

    ANN ARBOR, Mich., June 19, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) ...

    author_avatar
    NASDAQ Market News

    Asterias Biotherapeutics Announces Closing of $10.4 Million Registered Direct Offering

    FREMONT, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a ...

    author_avatar
    NASDAQ Market News